Key Statistics
Market Cap$824.92M
P/E Ratio7.8
Div. Yield—
EPS (TTM)$2.06
52W High$21.03
52W Low$7.90
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees90
Price Performance
1 Week+6.23%
3 Month-13.03%
1 Year+82.67%
FinancialsAnnual · QuiverQuant
Revenue$57.42M
Assets$382.00M
Liabilities$169.00M
Net Income$55.19M loss
About
Theravance Biopharma, Inc., a diversified biopharmaceutical company, discovers, develops, and markets organ-selective drugs in the United States, Europe, and Asia. The company is headquartered in George Town, the Cayman Islands.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze TBPH with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.